Synopsis: Tube Investments of India Ltd. reported a healthy operational performance in Q4 FY26, driven by strong revenue growth across its engineering and mobility businesses. The company posted consolidated revenue of Rs. 6,215 crore during the March 2026 quarter,...
Synopsis: Shares of this stock surged 6% after the company reported a 133% YoY jump in FY26 PAT to Rs. 17,175 crore, backed by strong refining margins and a final dividend of Rs. 19.25 per share. The shares of the company are mainly engaged in the business of...
Synopsis: TRF Ltd., a Tata Group engineering and material handling equipment company, reported a weak performance for Q4 FY26 as the company slipped into losses due to lower revenue and negative operating margins. The company posted a net loss of Rs. 6.91 crore during...
Synopsis: OneSource Specialty Pharma shares faced a brutal sell-off today, Wednesday, May 13, 2026, after the company reported a massive 95.33% decline in Q4 net profit. Despite a sequential recovery driven by GLP-1 (Semaglutide) launches, the year-on-year collapse in...
Synopsis: Pfizer Limited reported steady Q4FY26 revenue growth driven by stable pharmaceutical demand and improved product mix. Although reported profit declined due to absence of last year’s exceptional gain, the company maintained healthy operational performance and...
Synopsis: HP Adhesives Ltd reported a weak performance for the quarter ended March 2026 as profitability came under pressure due to higher expenses and margin contraction. The company posted an operational loss during the quarter, while net profit slipped into the...
Synopsis: Sai Silks (Kalamandir) reported a spectacular 141.67% year-on-year surge in net profit to Rs. 32.65 crore for Q4 FY26. Backed by strong revenue growth and stable operating margins, the Hyderabad-based retailer has also announced a 75% dividend, signaling...
Synopsis: High Energy Batteries (India) Limited reported stable FY26 profitability despite lower Q4 revenue due to softer defence execution during the quarter. Improved cost control, lower expenses, and steady aerospace and naval battery demand supported margins,...
Synopsis:- Weighed down by a one-time lenalidomide shelf stock adjustment of Rs. 453 crore in North America, Dr. Reddy’s Laboratories reported a muted Q4 FY26 on paper, but its India, Europe, and Emerging Markets businesses posted double-digit growth, pointing...
Synopsis: A precision engineering firm’s profits nearly doubled in a year, driven by one clean energy business that now makes up the majority of its revenues, backed by record order inflows and improving margins. When a company’s profits jump 76% in a...
